The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PSA response in black and white patients treated with abiraterone acetate (AA) for metastatic castrate-resistant prostate cancer (mCRPC).
 
Sundhar Ramalingam
No Relationships to Disclose
 
Michael Sandon Humeniuk
No Relationships to Disclose
 
Rachel Hu
No Relationships to Disclose
 
Julia Rasmussen
No Relationships to Disclose
 
Patrick Healy
No Relationships to Disclose
 
Yuan Wu
No Relationships to Disclose
 
Michael Roger Harrison
Consulting or Advisory Role - Bayer
Research Funding - Argos Therapeutics; Bristol-Myers Squibb; Genentech; Pfizer
 
Andrew J. Armstrong
Honoraria - Dendreon; Sanofi
Consulting or Advisory Role - Bayer; Dendreon; Janssen Biotech; Medivation; Novartis; Sanofi
Speakers' Bureau - Dendreon; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); ImClone Systems (Inst); Janssen Oncology (Inst); KangLaiTe (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture technology (Inst)
Travel, Accommodations, Expenses - Dendreon; Janssen Biotech; Medivation
 
Daniel J. George
Honoraria - Bayer; Dendreon; Medivation; Novartis; Sanofi
Consulting or Advisory Role - Acceleron Pharma; Astellas Pharma; Bayer; Bristol-Myers Squibb; Celgene; Clovis Oncology; Dendreon; Exelixis; Genentech; GlaxoSmithKline; Innocrin Pharma; Janssen; Medivation; Merck Sharp & Dohme; Novartis; Pfizer; Sanofi
Speakers' Bureau - Bayer; Dendreon; Novartis; Sanofi
Research Funding - Acerta Pharma (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Exelixis (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Viamet Pharmaceuticals (Inst)
 
Tian Zhang
Consulting or Advisory Role - Bayer; G1 Therapeutics
Research Funding - Acerta Pharma; Janssen
Other Relationship - Capio BioSciences (I)